50. 皮膚筋炎／多発性筋炎 ［臨床試験数：157，薬物数：207（DrugBank：76），標的遺伝子数：47，標的パスウェイ数：142］
Searched query = "Dermatomyositis", "Polymyositis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
|1||EUCTR2005-002463-88-IT||17/08/2006||21/04/2006||fficacy and safety of a human normal immunoglobulin product for intravenous administration (IVIg) in the treatment of dermatomyositis (DM) and polymyositis (PM)||Efficacy and safety of a human normal immunoglobulin product for intravenous administration (IVIg) in the treatment of dermatomyositis (DM) and polymyositis (PM): prospective, randomised, double-blind, placebo-controlled study.||Idiopathic dermatomyositis and polymyositis with insufficiently improved muscle strength under conventional therapy (glucocorticosteroids associated with immunosuppressors). |
MedDRA version: 14.1Level: HLTClassification code 10003821Term: Muscular autoimmune disordersSystem Organ Class: 100000004870;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
|Trade Name: IGVENA*FL 200ML 10G+SET||ORFAGEN||NULL||Not Recruiting||Female: yes|